Pimobendan – 50 mg

Brand:
Cayman
CAS:
74150-27-9
Storage:
-20
UN-No:
Non-Hazardous - /

Pimobendan is an inhibitor of phosphodiesterase 3 (PDE3; IC50 = 0.32 μM for guinea pig cardiac enzyme) that is selective for PDE3 over PDE1, PDE2, and PDE4 (IC50s = >30 μM).{46297} It is also a calcium sensitizer, decreasing the concentration of calcium required for half-maximal contractile force in isolated, skinned porcine ventricular fibers. Pimobendan increases the force of contraction in electrically-stimulated isolated guinea pig papillary muscles with an EC50 value of 6 μM, indicating positive inotropic effects.{46298} It increases survival time in dogs with congestive heart failure due to myxomatous mitral valve disease when administered in combination with angiotensin-converting enzyme inhibitors and furosemide (Item No. 17273).{46299} Formulations containing pimobendan have been used in the treatment of heart failure in dogs.  

 

Available on backorder

SKU: 26082 - 50 mg Category:

Description

An inhibitor of PDE3 (IC50 = 0.32 μM for guinea pig cardiac enzyme); selective for PDE3 over PDE1, PDE2, and PDE4 (IC50s = >30 μM); a calcium sensitizer, decreasing the concentration of calcium required for half-maximal contractile force in isolated, skinned porcine ventricular fibers; increases the force of contraction in electrically-stimulated isolated guinea pig papillary muscles (EC50 = 6 μM); increases survival time in dogs with congestive heart failure due to myxomatous mitral valve disease when administered in combination with angiotensin-converting enzyme inhibitors and furosemide


Formal name: 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl-3(2H)-pyridazinone

Synonyms:  UD-CG 115

Molecular weight: 334.4

CAS: 74150-27-9

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Phosphodiesterases||Research Area|Cardiovascular System|Cardiovascular Diseases|Heart Failure||Research Area|Cardiovascular System|Heart|Myocardial Contractility